Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy-Reference-Cited by-同舟云学术

Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy

Published:2018-05-30 Issue:16 Volume:27 Page:2874-2892
ISSN:0964-6906
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Tapias Victor¹^ORCID,Jainuddin Shari¹,Ahuja Manuj²,Stack Cliona¹,Elipenahli Ceyhan¹,Vignisse Julie³,Gerges Meri¹,Starkova Natalia¹,Xu Hui¹,Starkov Anatoly A¹,Bettendorff Lucien³,Hushpulian Dmitry M⁴⁵,Smirnova Natalya A⁴,Gazaryan Irina G⁶⁷,Kaidery Navneet A²,Wakade Sushama²,Calingasan Noel Y¹,Thomas Bobby²,Gibson Gary E¹⁸,Dumont Magali¹,Beal M Flint¹

Affiliation:

1. Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY 10065, USA

2. Department of Pharmacology, Toxicology and Neurology, Augusta University, Augusta, GA 30912, USA

3. Laboratory of Neurophysiology, GIGA-Neurosciences, University of Liege, 4000 Liege, Belgium

4. D. Rogachev Federal Scientific and Clinical Center for Pediatric Hematology, Oncology, and Immunology, 117997 Moscow, Russia

5. Veropharm, Abbott EPD, 115088 Moscow, Russia

6. Department of Chemistry and Physical Sciences, Pace University, Pleasantville, NY 10570, USA

7. Department of Enzymology, School of Chemistry, 119991 Moscow, Russia

8. Burke Medical Research Institute, Weill Cornell Medicine, White Plains, NY 10605, USA

Funder

National Institute on Aging

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Genetics (clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/27/16/2874/25428296/ddy201.pdf

Reference94 articles.

1. Thiamin diphosphate in biological chemistry: new aspects of thiamin metabolism, especially triphosphate derivatives acting other than as cofactors;Bettendorff;FEBS J,2009

2. Thiamine homeostasis in neuroblastoma cells;Bettendorff;Neurochem. Int,1995

3. Thiamine, thiamine phosphates, and their metabolizing enzymes in human brain;Bettendorff;J. Neurochem,2002

4. Thiamine status in humans and content of phosphorylated thiamine derivatives in biopsies and cultured cells;Gangolf;PLoS One,2010

5. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer’s disease;Gibson;Arch. Neurol,1988

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the AKT/ERK cascade and its role in Parkinson disease;Archives of Toxicology;2024-08-13

2. Exploring the Therapeutic Potential of Benfotiamine in a Sporadic Alzheimer’s-Like Disease Rat Model: Insights into Insulin Signaling and Cognitive function;ACS Chemical Neuroscience;2024-07-15

3. Pharmacological Doses of Thiamine Benefit Patients with the Charcot–Marie–Tooth Neuropathy by Changing Thiamine Diphosphate Levels and Affecting Regulation of Thiamine-Dependent Enzymes;Biochemistry (Moscow);2024-07

4. Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam);PLOS ONE;2024-05-29

5. Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam);2024-04-19